U.S. Clinical Trials Begin for COVID-19 Oral Therapeutics Discovered Using LSU-Developed Artificial Intelligence
November 04, 2021
November 04, 2021
BATON ROUGE, Louisiana, Nov. 4 (TNSRes) -- Louisiana State University issued the following news release:
* * *
First patient study in North America to investigate a new combination of two previously FDA-approved drugs identified as effective against COVID-19 by DeepDrug, an artificial intelligence platform developed by Louisiana State University (LSU) researchers.
* * *
Skymount Medical has partnered with Riverside University Health System (RUH . . .
* * *
First patient study in North America to investigate a new combination of two previously FDA-approved drugs identified as effective against COVID-19 by DeepDrug, an artificial intelligence platform developed by Louisiana State University (LSU) researchers.
* * *
Skymount Medical has partnered with Riverside University Health System (RUH . . .